<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="122007">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01514396</url>
  </required_header>
  <id_info>
    <org_study_id>R11-018</org_study_id>
    <nct_id>NCT01514396</nct_id>
  </id_info>
  <brief_title>Skin Incision Adhesive in Pediatrics</brief_title>
  <official_title>Evaluation of Surgiseal as a Topical Emergency Department Skin Incision Adhesive in Pediatrics A Case Series</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medline Industries</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medline Industries</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of on-label use of Surgisealâ„¢
      Tissue Adhesive, a cyanoacrylate-based Surgical Topical Skin Tissue Adhesive in wound
      closure of the topical skin in children presenting in the Emergency Department (ED).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wound closure</measure>
    <time_frame>2-14 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of subjects with adverse events related to wound closure</measure>
    <time_frame>2-14 days</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Wounds</condition>
  <arm_group>
    <arm_group_label>Surgical Glue</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Surgiseal</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Surgiseal</intervention_name>
    <description>surgical glue</description>
    <arm_group_label>Surgical Glue</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between the ages of 5 and 18 years of age, inclusive

          -  Candidate for use of a topical surgical skin adhesive

          -  Informed consent by a parental guardian

        Exclusion Criteria:

          -  A wound with evidence of active infection or gangrene or wounds of decubitus etiology

          -  Mucosal surfaces or across mucocutaneous junctions or skin that might be exposed to
             body fluids or dense natural hair

          -  Subjects with known hypersensitivity to cyanoacrylate or formaldehyde
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>JCMC</name>
      <address>
        <city>Nersey City</city>
        <state>New York</state>
        <zip>07302</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Wyckoff Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Akron Children's Hospital Emergency Department</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Lloyd, RN</last_name>
      <phone>330-543-4578</phone>
    </contact>
    <investigator>
      <last_name>Eric Lloyd, RN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 24, 2014</lastchanged_date>
  <firstreceived_date>January 12, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pediatric</keyword>
  <keyword>Wounds</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
